Thomas F. Eleveld

Utrecht, UT, Netherlands

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications

Reply to: Time-Varying Effects of Copy Number Alteration Clustering: Methodologic Concerns in Survival Analysis of Relapsed/Refractory Germ Cell Tumors.

Reply to: Time-Varying Effects of Copy Number Alteration Clustering: Methodologic Concerns in Survival Analysis of Relapsed/Refractory Germ Cell Tumors.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: July 27, 2026

Impact of Circulating Tumor DNA and Copy-Number Alterations on Clinical Outcome in Relapsed/Refractory Germ Cell Tumors Treated With Salvage High-Dose Chemotherapy.

Impact of Circulating Tumor DNA and Copy-Number Alterations on Clinical Outcome in Relapsed/Refractory Germ Cell Tumors Treated With Salvage High-Dose Chemotherapy.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: February 19, 2026

Identification and validation of liquid biopsy-based methylation biomarkers for germ cell tumor subtypes.

Identification and validation of liquid biopsy-based methylation biomarkers for germ cell tumor subtypes.

Journal: Communications medicine
Published: August 22, 2025

Yolk Sac Elements in Tumors Derived from Pluripotent Stem Cells: Borrowing Knowledge from Human Germ Cell Tumors.

Yolk Sac Elements in Tumors Derived from Pluripotent Stem Cells: Borrowing Knowledge from Human Germ Cell Tumors.

Journal: International journal of molecular sciences
Published: May 23, 2025

Chromosome-specific aberrations, rather than general aneuploidy, may drive mouse embryonic stem cell-derived teratoma metastasis.

Chromosome-specific aberrations, rather than general aneuploidy, may drive mouse embryonic stem cell-derived teratoma metastasis.

Journal: Stem cell research & therapy
Published: March 04, 2025

Clinical syndromes linked to biallelic germline variants in MCM8 and MCM9.

Clinical syndromes linked to biallelic germline variants in MCM8 and MCM9.

Journal: HGG advances
Published: December 16, 2024

Low-amplitude copy number gains shape cancer through known and novel oncogenes with associated therapeutic vulnerabilities.

Low-amplitude copy number gains shape cancer through known and novel oncogenes with associated therapeutic vulnerabilities.

Journal: Nucleic acids research
Published: October 25, 2024

Depletion of TP53 in Human Pluripotent Stem Cells Triggers Malignant-Like Behavior.

Depletion of TP53 in Human Pluripotent Stem Cells Triggers Malignant-Like Behavior.

Journal: Advanced biology
Published: September 12, 2024

Feeder-free culture of human pluripotent stem cells drives MDM4-mediated gain of chromosome 1q.

Feeder-free culture of human pluripotent stem cells drives MDM4-mediated gain of chromosome 1q.

Journal: Stem cell reports
Published: May 24, 2024

MEK inhibition causes BIM stabilization and increased sensitivity to BCL-2 family member inhibitors in RAS-MAPK-mutated neuroblastoma.

MEK inhibition causes BIM stabilization and increased sensitivity to BCL-2 family member inhibitors in RAS-MAPK-mutated neuroblastoma.

Journal: Frontiers in oncology
Published: December 22, 2022

Chromosome 11q loss and MYCN amplification demonstrate synthetic lethality with checkpoint kinase 1 inhibition in neuroblastoma.

Chromosome 11q loss and MYCN amplification demonstrate synthetic lethality with checkpoint kinase 1 inhibition in neuroblastoma.

Journal: Frontiers in oncology
Published: April 26, 2022

Chromosome 3p25.3 Gain Is Associated With Cisplatin Resistance and Is an Independent Predictor of Poor Outcome in Male Malignant Germ Cell Tumors.

Chromosome 3p25.3 Gain Is Associated With Cisplatin Resistance and Is an Independent Predictor of Poor Outcome in Male Malignant Germ Cell Tumors.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: April 20, 2022
Showing 1-12 of 18

Last Updated: 09/26/2026